<VariationArchive VariationID="1918199" VariationName="NM_001972.4(ELANE):c.538del (p.Leu180fs)" VariationType="Deletion" Accession="VCV001918199" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2023-02-07" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1978410" VariationID="1918199">
      <GeneList>
        <Gene Symbol="ELANE" FullName="elastase, neutrophil expressed" GeneID="1991" HGNC_ID="HGNC:3309" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="852303" stop="856243" display_start="852303" display_stop="856243" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NT_187622.1" start="29537" stop="35129" display_start="29537" display_stop="35129" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="852290" stop="856245" display_start="852290" display_stop="856245" Strand="+" />
          </Location>
          <OMIM>130130</OMIM>
          <Haploinsufficiency last_evaluated="2022-07-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ELANE">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-07-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ELANE">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001972.4(ELANE):c.538del (p.Leu180fs)</Name>
      <CanonicalSPDI>NC_000019.10:855732:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="855733" stop="855733" display_start="855733" display_stop="855733" variantLength="1" positionVCF="855732" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="855733" stop="855733" display_start="855733" display_stop="855733" variantLength="1" positionVCF="855732" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L180fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_46" sequenceAccession="LRG_46">
            <Expression>LRG_46:g.1071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.855735del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.855735del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007274.1" sequenceAccession="NG_007274" sequenceVersion="1" change="g.1071del">
            <Expression>NG_007274.1:g.1071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009627.1" sequenceAccession="NG_009627" sequenceVersion="1" change="g.8445del">
            <Expression>NG_009627.1:g.8445del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001972.4" sequenceAccession="NM_001972" sequenceVersion="4" change="c.538del" MANESelect="true">
            <Expression>NM_001972.4:c.538del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001963.1" sequenceAccession="NP_001963" sequenceVersion="1" change="p.Leu180fs">
            <Expression>NP_001963.1:p.Leu180fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.855735del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.855735del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_57" sequenceAccession="LRG_57">
            <Expression>LRG_57:g.8445del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_57t1" sequenceAccession="LRG_57t1">
            <Expression>LRG_57t1:c.538del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_57p1" sequenceAccession="LRG_57p1" change="p.Leu180Serfs">
            <Expression>LRG_57p1:p.Leu180Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001972.4(ELANE):c.538del (p.Leu180fs) AND multiple conditions" Accession="RCV002601841" Version="2">
        <ClassifiedConditionList TraitSetID="69418">
          <ClassifiedCondition DB="MedGen" ID="C0221023">Cyclical neutropenia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1859966">Neutropenia, severe congenital, 1, autosomal dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-07" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23463630</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31574885</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33513358</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34340247</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36734404</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="69418" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1694" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cyclical neutropenia</ElementValue>
                <XRef ID="Cyclic+Hematopoiesis/2064" DB="Genetic Alliance" />
                <XRef ID="191347008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cyclic hematopoiesis</ElementValue>
                <XRef ID="MONDO:0008090" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">ELANE-Related Neutropenia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6229" />
                <XRef ID="6229" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000521914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528303" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529138" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530631" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552055" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500009" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593753" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia. In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia (AML) is approximately 15%-25%. Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.</Attribute>
                <XRef ID="NBK1533" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301705</ID>
                <ID Source="BookShelf">NBK1533</ID>
              </Citation>
              <XRef ID="2686" DB="Orphanet" />
              <XRef ID="C0221023" DB="MedGen" />
              <XRef ID="MONDO:0008090" DB="MONDO" />
              <XRef Type="MIM" ID="162800" DB="OMIM" />
              <XRef Type="primary" ID="HP:0040289" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="3464" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neutropenia, severe congenital, 1, autosomal dominant</ElementValue>
                <XRef ID="MONDO:0042490" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SCN1</ElementValue>
                <XRef Type="MIM" ID="202700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Severe Congenital Neutropenia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ELANE-Related Neutropenia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia. In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia (AML) is approximately 15%-25%. Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.</Attribute>
                <XRef ID="NBK1533" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301705</ID>
                <ID Source="BookShelf">NBK1533</ID>
              </Citation>
              <XRef ID="C1859966" DB="MedGen" />
              <XRef ID="MONDO:0042490" DB="MONDO" />
              <XRef Type="MIM" ID="202700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5638577" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="12683421|MedGen:C1859966;C0221023" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002956923" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31574885</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">36734404</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33513358</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23463630</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34340247</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu180Serfs*11) in the ELANE gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 88 amino acid(s) of the ELANE protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with cyclic neutropenia or severe congenital neutropenia (PMID: 31574885, 36734404). ClinVar contains an entry for this variant (Variation ID: 1918199). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant is located in a region of the ELANE protein where a significant number of ELANE nonsense and -1/+2 frameshift mutations have been reported in association with autosomal dominant ELANE-related neutropenia (PMID: 33513358, 23463630, 34340247). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELANE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.855733del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859966" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0221023" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5638577" TraitType="Disease" MappingType="XRef" MappingValue="C0221023" MappingRef="MedGen">
        <MedGen CUI="C0221023" Name="Cyclical neutropenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5638577" TraitType="Disease" MappingType="XRef" MappingValue="C1859966" MappingRef="MedGen">
        <MedGen CUI="C1859966" Name="Neutropenia, severe congenital, 1, autosomal dominant" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

